Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05705219 · ClinicalTrials.gov registry record
Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients
A clinical trial of Liver Cancer, Adult, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- 80
- Enrollment target
- 3
- Study locations
NCT05705219: Recruiting study of Liver Cancer, Adult, sponsored by University of California, San Diego.
NCT05705219 is a study of Liver Cancer, Adult that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 80 participants, above the 65-participant average among 3 other Liver Cancer, Adult trials with a reported enrollment target (23% higher). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05705219, a study of Liver Cancer, Adult, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- 80 participants
- Enrollment target
- 3
- Study locations
Study Summary
This clinical trial studies how well 3-dimensional multi-parametric ultrasound (3D MPUS) imaging works as a decision-support tool for patients with liver tumors undergoing therapy. Continuous and dynamic imaging of patients undergoing therapy is required to monitor early-phase treatment response.
Primary Outcome
Diagnostic yield will be the percentage of non-missing measurements (per reader, per measurement) Participants with successful measurements of the following parameters (following administration of a contrast agent). * peak enhancement (PE)
Conditions Studied
Interventions
- DIAGNOSTIC_TEST 3D-MPUS
Study Locations (3)
California
- Stanford University, School of Medicine - Palo Alto
- University of California, San Diego - San Diego
Pennsylvania
- Thomas Jefferson Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-12-04 |
| Est. Completion | 2028-12-31 |
What NCT05705219 shows while recruiting
NCT05705219 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target, above the 65-participant average among 3 other Liver Cancer, Adult trials with a reported enrollment target (23% higher).
The record links to 1 condition, with Liver Cancer, Adult appearing as the primary indexed condition, and to 1 intervention - of which 3D-MPUS is the first listed.
NCT05705219 reports a single indexed study location in California, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05705219 about?
NCT05705219 is a clinical study titled "Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients". This clinical trial studies how well 3-dimensional multi-parametric ultrasound (3D MPUS) imaging works as a decision-support tool for patients with liver tumors undergoing therapy. Continuous and dynamic imaging of patients undergoing therapy is required to monitor early-phase treatment response.
What is the current status of trial NCT05705219?
This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2023-12-04. Estimated completion is 2028-12-31.
What conditions does trial NCT05705219 study?
This clinical trial studies the following conditions: Liver Cancer, Adult.
What interventions are being tested in trial NCT05705219?
The interventions under investigation include: 3D-MPUS (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05705219?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05705219 being conducted?
This trial has 3 study locations across California, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Cancer, Adult
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
To Test Whether Time-restricted Eating Coupled With a Healthy Diet is Beneficial in Liver Cancer Patients
RECRUITING · NA
-
T-Cell Therapy (ECT204) in Adults With Advanced HCC
RECRUITING · Phase 1
-
Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI